ATXS
Price
$4.96
Change
+$0.18 (+3.77%)
Updated
Jun 3 closing price
Capitalization
279.91M
68 days until earnings call
TRDA
Price
$8.47
Change
+$0.24 (+2.91%)
Updated
Jun 4, 10:37 AM (EDT)
Capitalization
312.74M
63 days until earnings call
Interact to see
Advertisement

ATXS vs TRDA

Header iconATXS vs TRDA Comparison
Open Charts ATXS vs TRDABanner chart's image
Astria Therapeutics
Price$4.96
Change+$0.18 (+3.77%)
Volume$456.27K
Capitalization279.91M
Entrada Therapeutics
Price$8.47
Change+$0.24 (+2.91%)
Volume$1.2K
Capitalization312.74M
ATXS vs TRDA Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. TRDA commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ATXS: $4.96 vs. TRDA: $8.24)
Brand notoriety: ATXS and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 86% vs. TRDA: 75%
Market capitalization -- ATXS: $279.91M vs. TRDA: $312.74M
ATXS [@Biotechnology] is valued at $279.91M. TRDA’s [@Biotechnology] market capitalization is $312.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, TRDA is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 3 bearish.
  • TRDA’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than ATXS.

Price Growth

ATXS (@Biotechnology) experienced а +21.27% price change this week, while TRDA (@Biotechnology) price change was +7.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ATXS is expected to report earnings on Aug 11, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($313M) has a higher market cap than ATXS($280M). ATXS YTD gains are higher at: -44.519 vs. TRDA (-52.342). TRDA has higher annual earnings (EBITDA): 7.89M vs. ATXS (-111.56M). TRDA has more cash in the bank: 383M vs. ATXS (328M). ATXS has less debt than TRDA: ATXS (5.35M) vs TRDA (57M). TRDA has higher revenues than ATXS: TRDA (172M) vs ATXS (0).
ATXSTRDAATXS / TRDA
Capitalization280M313M89%
EBITDA-111.56M7.89M-1,413%
Gain YTD-44.519-52.34285%
P/E RatioN/A14.21-
Revenue0172M-
Total Cash328M383M86%
Total Debt5.35M57M9%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSTRDA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 27 days ago
90%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITHSX52.10N/A
N/A
Hartford Capital Appreciation R4
KSOCX154.90N/A
N/A
Kinetics Small Cap Opportunities Adv C
LMCMX8.32N/A
N/A
Miller Income IS
PSMKX52.32N/A
N/A
Victory Pioneer Select Mid Cap Growth R6
GEMWX12.56N/A
N/A
Goldman Sachs Emerging Mkt Eq ex. Chn R6

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with TRDA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+3.77%
TRDA - ATXS
53%
Loosely correlated
+1.23%
KYMR - ATXS
53%
Loosely correlated
+1.04%
CRNX - ATXS
53%
Loosely correlated
+0.69%
XENE - ATXS
51%
Loosely correlated
+2.16%
DNLI - ATXS
51%
Loosely correlated
-0.21%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+1.23%
CRNX - TRDA
56%
Loosely correlated
+0.69%
RXRX - TRDA
54%
Loosely correlated
+0.46%
ATXS - TRDA
54%
Loosely correlated
+3.77%
IMNM - TRDA
52%
Loosely correlated
+2.21%
BEAM - TRDA
52%
Loosely correlated
+4.26%
More